Cabaletta Bio CABA
NASDAQ CABA
$3.46 -0.02 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2026)

Cabaletta Bio (CABA) posted quarterly Interest & Investment Income of $1.3 million for Q4 2025, down 31.9% year-over-year from $1.9 million in Q4 2024, and down 26.66% quarter-over-quarter from $1.8 million in Q3 2025.

Analysis

Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2026) Analysis & Trends

Cabaletta Bio's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $1.3 million for Q4 2025.

  • In Q4 2025, Interest & Investment Income fell 31.9% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $6.0 million (down 39.84% YoY), while the FY2025 annual figure was $6.0 million, down 39.84% from the prior year.
  • Interest & Investment Income for Q4 2025 stood at $1.3 million, down from $1.8 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $3.0 million in Q1 2024, with the low at $3000.0 in Q3 2021.
  • The 5-year median for Interest & Investment Income is $1.4 million (2023), against an average of $1.2 million.
  • The sharpest annual moves came in 2021 and 2022: Interest & Investment Income tumbled 97.56% in 2021, then surged 12100.0% in 2022.
  • Cabaletta Bio's Interest & Investment Income stood at $5000.0 in 2021, then soared by 12100.0% to $610000.0 in 2022, then jumped by 270.49% to $2.3 million in 2023, then slipped by 13.85% to $1.9 million in 2024, then sank by 31.9% to $1.3 million in 2025.
  • Business Quant data shows CABA's Interest & Investment Income at $1.3 million in Q4 2025, $1.8 million in Q3 2025, and $1.4 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Cabaletta Bio 522.26 Mn 522.26 Mn - 1.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Dec 31, 2025 1.33 Mn
Sep 30, 2025 1.81 Mn
Jun 30, 2025 1.41 Mn
Mar 31, 2025 1.49 Mn
Dec 31, 2024 1.95 Mn
Sep 30, 2024 2.42 Mn
Jun 30, 2024 2.68 Mn
Mar 31, 2024 2.98 Mn
Dec 31, 2023 2.26 Mn
Sep 30, 2023 2.22 Mn
Jun 30, 2023 1.40 Mn
Mar 31, 2023 1.10 Mn
Dec 31, 2022 610,000.00
Sep 30, 2022 351,000.00
Jun 30, 2022 150,000.00
Mar 31, 2022 53,000.00
Dec 31, 2021 5,000.00
Sep 30, 2021 3,000.00
Jun 30, 2021 6,000.00